✦ LIBER ✦

Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C

✍ Scribed by M. Friedrich-Rust; J. Theobald; S. Zeuzem; J. Bojunga

Book ID: 108886214
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 262 KB
Volume: 16
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2008.01059.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neutrophil Function and Apoptosis in Pat

Neutrophil Function and Apoptosis in Patients with Chronic Hepatitis C Treated with Pegylated Interferon α and Ribavirin

✍ Elżbieta Jabłonowska; Kamila Wójcik; Barbara Kur; Przemysław Lewkowicz; Marek No 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 417 KB

Retinopathy in hepatitis C patients due

Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin

✍ Ei Tae Kim; Lee Hoo Kim; Jung Il Lee; Hee Seung Chin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Prospective study of bone mineral densit

Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

✍ W. P. Hofmann; B. Kronenberger; J. Bojunga; B. Stamm; E. Herrmann; A. Bücker; U 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Superior response to pegylated interfero

Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C

✍ Venessa Pattullo; E. Jenny Heathcote; David K. H. Wong 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

Investigation of hyperuricemia during pe

Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C

✍ Naoki YAMASHITA; Munechika ENJOJI; Kazuhiro KOTOH; Masaki KATO; Akihiro UEDA; Yu 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 122 KB

Antiviral activity of narlaprevir combin

Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients

✍ Joep de Bruijne; Jilling F. Bergmann; Henk W. Reesink; Christine J. Weegink; Ric 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 1 views

Narlaprevir (SCH 900518) is a potent inhibitor of the hepatitis C virus (HCV) nonstructural protein 3 serine protease that is primarily metabolized by the cytochrome P450-3A4 system. In order to explore the use of ritonavir-based pharmacokinetic enhancement of an HCV protease inhibitor, this study i